OnCo
peoplePerson

Thomas A. Hope

Nuclear medicine physician who led the trials that got PSMA PET approved in the United States.

Radiologist whose prospective studies of 68Ga-PSMA-11 PET at UCSF and UCLA supported the first FDA approval of PSMA PET in 2020. Leads theranostics research and PSMA radioligand dosimetry work.

Role
Professor of Radiology; Chief of Nuclear Medicine, UCSF
Specialisms
Nuclear medicinePSMA PETTheranostics

Papers

2top
TitleJournalYear
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialJAMA Oncology2021
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialJAMA Oncology2019

Connected

6top

cancers

1
Prostate cancer

technologies

3
PET (positron emission tomography)PSMA PETRadioligand therapy (beta emitters)

targets

1
PSMA

institutions

1
UCSF Helen Diller Family Comprehensive Cancer Center